Planung einer Inkontinenztherapie
Anmelder: Medtronic, Inc. 🇺🇸
Details
- Veröffentlichungs-Nr.
- EP4353303
- Aktenzeichen
- EP23202924
- Anmeldetag
- 11. Oktober 2023
- Veröffentlichung
- 21. August 2024
- Rechtsraum
- EP
- IPC
- A61N1/36A61N1/372G16H20/00G16H40/00
Abstract
In some examples, a system includes processing circuitry configured to receive a first set of information, the first set of information comprising information of actual therapy delivered to a patient over a plurality of instances of therapy delivery. The processing circuitry may determine, based upon the first set of information, a therapy usage pattern. The processing circuitry may determine a modification to a programmed therapy schedule based on the therapy usage pattern. The processing circuitry may generate for output the modification to the programmed therapy schedule.
Anmelder
- Firma
- Medtronic, Inc.
- Land
- 🇺🇸 USA
US-amerikanischer Medizintechnikkonzern, entwickelt Implantate, Geräte und Therapiesysteme unter anderem für Herz-Kreislauf-, Diabetes- und neurologische Erkrankungen.
4.790 Patente in unserer Datenbank